Co-encapsulation of magnetic Fe₃O₄ nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery

References

• HortobágyiGNAnthracyclines in the treatment of cancer: an overviewDrugs199754Suppl 417
   PubMed Web of Science ®Google Scholar
• GoodmanMFLeeGMAdriamycin interactions with T4 DNA polymerase: two modes of template-mediated inhibitionJ Biol Chem1977252826702674323251
   PubMed Web of Science ®Google Scholar
• GehlJBoesgaardMPaaskeTVittrup JensenBDombernowskyPCombined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxicAnn Oncol1996776876938905026
   PubMed Web of Science ®Google Scholar
• YousefpourPAtyabiFFarahaniEVSakhtianchiRDinarvandRPolyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluationsInt J Nanomedicine201161487149621796249
   PubMed Web of Science ®Google Scholar
• KangYMKimGHKimJIIn vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymerBiomaterials201132204556456421440935
   PubMed Web of Science ®Google Scholar
• GaoZGLeeDHKimDIBaeYHDoxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in miceJ Drug Target200513739139716308207
   PubMed Web of Science ®Google Scholar
• WeinbergBDAiHBlancoEAndersonJMGaoJAntitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirodsJ Biomed Mater Res A200781116117017120197
   PubMed Web of Science ®Google Scholar
• ChenYWanYWangYZhangHJiaoZAnticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticlesInt J Nanomedicine201162321232622072869
   PubMed Web of Science ®Google Scholar
• Al-AbdAMHongKYSongSCKuhHJPharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing miceJ Control Release2010142110110719819274
   PubMed Web of Science ®Google Scholar
• XieMZhouLHuTYaoMIntratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenograftsAnticancer Drugs200718445946617351398
   PubMed Web of Science ®Google Scholar
• EmerichDFSnodgrassPLafreniereDSustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusionsPharm Res20021971052106012180539
   PubMed Web of Science ®Google Scholar
• ChangGTLiCLuWYDingJDN-Boc-histidine-capped PLGA-PEG- PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pHMacromol Biosci201010101248125620593367
   PubMed Web of Science ®Google Scholar
• XuXLChenXSWangZFJingXBUltrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicityEur J Pharm Biopharm2009721182519027067
   PubMed Web of Science ®Google Scholar
• XieJHuangJLiXSunSChenXIron oxide nanoparticle platform for biomedical applicationsCurr Med Chem200916101278129419355885
   PubMed Web of Science ®Google Scholar
• ChenBChengJShenMMagnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
   PubMed Web of Science ®Google Scholar
• WangJChenYChenBPharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in miceInt J Nanomedicine2010586186621042548
   PubMed Web of Science ®Google Scholar
• NeubergerTSchopfBHofmannHHofmannMvon RechenbergBSuperparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery systemJ Magn Magn Mater20052931483496
   Web of Science ®Google Scholar
• ArrueboMFernández-PachecoRIbarraMRSantamaríaJMagnetic nanoparticles for drug deliveryNano Today2007232232
   Web of Science ®Google Scholar
• McBainSCYiuHHDobsonJMagnetic nanoparticles for gene and drug deliveryInt J Nanomedicine20083216918018686777
   PubMed Web of Science ®Google Scholar
• WidderKJMorrisRMPooreGHowardDPJrSenyeiAETumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicinProc Natl Acad Sci U S A19817815795816941258
   PubMed Web of Science ®Google Scholar
• LübbeASBergemannCHuhntWPreclinical experiences with magnetic drug targeting: tolerance and efficacyCancer Res19965620469447018840986
   PubMed Web of Science ®Google Scholar
• LübbeASBergemannCRiessHClinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumorsCancer Res19965620468646938840985
   PubMed Web of Science ®Google Scholar
• AlexiouCJurgonsRSchmidRJMagnetic drug targeting–biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatmentJ Drug Target200311313914913129824
   PubMed Web of Science ®Google Scholar
• ChariRVTargeted cancer therapy: conferring specificity to cytotoxic drugsAcc Chem Res20084119810717705444
   PubMed Web of Science ®Google Scholar
• MurakamiTTsuchidaKHashidaMImahoriHSize control of lipid-based drug carrier by drug loadingMol Biosyst20106578979120567763
   PubMedGoogle Scholar
• PatilRRGuhagarkarSADevarajanPVEngineered nanocarriers of doxorubicin: a current updateCrit Rev Ther Drug Carrier Syst200825116118540835
   PubMed Web of Science ®Google Scholar
• KataokaKMatsumotoTYokoyamaMDoxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significanceJ Control Release2000641–314315310640653
   PubMed Web of Science ®Google Scholar
• SpringateCMJacksonJKGleaveMEBurtHMClusterin antisense complexed with chitosan for controlled intratumoral deliveryInt J Pharm20083501–2536417890029
   PubMed Web of Science ®Google Scholar
• GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
   PubMed Web of Science ®Google Scholar
• ChoiHSLiuWMisraPRenal clearance of quantum dotsNat Biotechnol200725101165117017891134
   PubMed Web of Science ®Google Scholar
• ChoulyCPouliquenDLucetIJeuneJJJalletPDevelopment of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistributionJ Microencapsul19961332452558860681
   PubMed Web of Science ®Google Scholar
• GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
   PubMed Web of Science ®Google Scholar
• YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release200068341943110974396
   PubMed Web of Science ®Google Scholar
• StubbsMMcSheehyPMGriffithsJRBashfordCLCauses and consequences of tumour acidity and implications for treatmentMol Med Today200061151910637570
   PubMedGoogle Scholar
• TannockIFRotinDAcid pH in tumors and its potential for therapeutic exploitationCancer Res19894916437343842545340
   PubMed Web of Science ®Google Scholar
• WangHZhaoYWuYEnhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesBiomaterials201132328281829021807411
   PubMed Web of Science ®Google Scholar
• DesaiMPLabhasetwarVWalterELevyRJAmidonGLThe mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependentPharm Res19971411156815739434276
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
   PubMed Web of Science ®Google Scholar
• JordanAScholzRSchnoyNWustPMaier-HauffKFelixRDifferential endocytosis of magnetic fluid particles into human primary glioblastoma, neuronal and fibroblast cells in vitroEur J Cell Biol1997Suppl 4732
   Google Scholar
• WeisslederRKellyKSunEYShtatlandTJosephsonLCell-specific targeting of nanoparticles by multivalent attachment of small moleculesNat Biotechnol200523111418142316244656
   PubMed Web of Science ®Google Scholar
• KohlerNSunCWangJZhangMMethotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cellsLangmuir200521198858886416142971
   PubMed Web of Science ®Google Scholar
• HuangXTengXChenDTangFHeJThe effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell functionBiomaterials201031343844819800115
   PubMed Web of Science ®Google Scholar
• KohlerNSunCFichtenholtzAGunnJFangCZhangMMethotrexate- immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug deliverySmall20062678579217193123
   PubMed Web of Science ®Google Scholar
• ChenBChengJWuYReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-miceInt J Nanomedicine20094737819421372
   PubMed Web of Science ®Google Scholar
• JiangZChenBAXiaGHThe reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cellsInt J Nanomedicine2009410711419516889
   PubMed Web of Science ®Google Scholar
• WidderKJSenyeiAERanneyDFIn vitro release of biologically active Adriamycin by magnetically responsive albumin microspheresCancer Res19804010351235177438037
   PubMed Web of Science ®Google Scholar
• GuptaPKHungCTMagnetically controlled targeted chemotherapyWillmottNDalyJMicrospheres and Regional Cancer TherapyBoca Raton, FLCRC Press199371116
   Google Scholar